General Information
Zanubrutinib is a small molecule inhibitor of Bruton tyrosine kinase, with more selectivity compared with approved agents in its class, like ibrutinib.
About the API
Systematic name
(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Trade name(s)
BRUKINSA
Technology
Synthetic
Molecular Formula
C27H29N5O3
Therapeutic category
Oncology
Available formulations
Oral Solid Long-Acting